Skip to main content

MoneyWorks4Me

A decrease of about -40.18% in the sales to Rs. 114.61 millions was observed for the quarter ended March 2023. The sales stood at Rs. 191.58 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2023 is Rs. -69.39 millions as compared to Net Loss of Rs. -113.15 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 improved to -44.31% as compared to -89.86% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 114.61 191.58 -40.18 521.34 597.03 -12.68 521.34 597.03 -12.68
Other Income 1.93 7.93 -75.66 6.20 11.56 -46.37 6.20 11.56 -46.37
PBIDT -44.31 -89.86 -50.69 -151.59 -328.39 -53.84 -151.59 -328.39 -53.84
Interest 10.28 2.80 267.14 29.73 53.91 -44.85 29.73 53.91 -44.85
PBDT -54.59 -92.66 -41.09 -181.32 -382.30 -52.57 -181.32 -382.30 -52.57
Depreciation 14.80 20.49 -27.77 65.59 62.97 4.16 65.59 62.97 4.16
PBT -69.39 -113.15 -38.67 -246.91 -445.27 -44.55 -246.91 -445.27 -44.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -69.39 -113.15 -38.67 -246.91 -445.27 -44.55 -246.91 -445.27 -44.55
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -38.66 -46.90 -17.57 -29.08 -55.00 -47.14 -29.08 -55.00 -47.14
Peers
Company Name CMP
Sun Pharma. Inds. 1800.05
Dr. Reddys Labs. 1362.85
Cipla 1395.80
Lupin 2044.00
Zydus Lifesciences 1255.55
View more..